PBH Prestige Consumer Healthcare Inc

Price (delayed)

$52.58

Market cap

$2.62B

P/E Ratio

16.03

Dividend/share

N/A

EPS

$3.28

Enterprise value

$4.11B

Highlights
The EPS has grown by 17% YoY
The net income has grown by 16% YoY
PBH's P/E is 35% above its last 4 quarters average of 11.9
The quick ratio has decreased by 27% YoY and by 15% from the previous quarter

Key stats

What are the main financial stats of PBH
Market
Shares outstanding
49.91M
Market cap
$2.62B
Enterprise value
$4.11B
Valuations
Price to earnings (P/E)
16.03
Price to book (P/B)
1.93
Price to sales (P/S)
2.8
EV/EBIT
14.34
EV/EBITDA
12.69
EV/Sales
4.35
Earnings
Revenue
$943.37M
EBIT
$286.44M
EBITDA
$323.69M
Free cash flow
$213.36M
Per share
EPS
$3.28
Free cash flow per share
$4.25
Book value per share
$27.24
Revenue per share
$18.79
TBVPS
$7.48
Balance sheet
Total assets
$3.43B
Total liabilities
$2.07B
Debt
$1.51B
Equity
$1.36B
Working capital
$147.7M
Liquidity
Debt to equity
1.12
Current ratio
2.21
Quick ratio
1.2
Net debt/EBITDA
4.58
Margins
EBITDA margin
34.3%
Gross margin
58%
Net margin
17.5%
Operating margin
31.5%
Efficiency
Return on assets
4.8%
Return on equity
12.7%
Return on invested capital
15.9%
Return on capital employed
8.7%
Return on sales
30.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PBH stock price

How has the Prestige Consumer Healthcare stock price performed over time
Intraday
0.06%
1 week
2.18%
1 month
0.75%
1 year
37.75%
YTD
50.79%
QTD
0.92%

Financial performance

How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$943.37M
Gross profit
$547.47M
Operating income
$297.4M
Net income
$164.68M
Gross margin
58%
Net margin
17.5%
The company's net margin rose by 18% YoY
The net income has grown by 16% YoY
PBH's operating margin is up by 4.3% year-on-year
Prestige Consumer Healthcare's revenue has decreased by 2% YoY

Growth

What is Prestige Consumer Healthcare's growth rate over time

Valuation

What is Prestige Consumer Healthcare stock price valuation
P/E
16.03
P/B
1.93
P/S
2.8
EV/EBIT
14.34
EV/EBITDA
12.69
EV/Sales
4.35
PBH's P/E is 35% above its last 4 quarters average of 11.9
The EPS has grown by 17% YoY
PBH's price to book (P/B) is 29% higher than its last 4 quarters average of 1.5 but 3.5% lower than its 5-year quarterly average of 2.0
The equity has grown by 16% YoY and by 2.7% from the previous quarter
The price to sales (P/S) is 40% higher than the last 4 quarters average of 2.0 and 27% higher than the 5-year quarterly average of 2.2
Prestige Consumer Healthcare's revenue has decreased by 2% YoY

Efficiency

How efficient is Prestige Consumer Healthcare business performance
Prestige Consumer Healthcare's return on assets has increased by 17% YoY
Prestige Consumer Healthcare's ROIC has increased by 10% YoY
PBH's ROE is down by 4.5% QoQ
The ROS has contracted by 3.2% from the previous quarter but it has grown by 2% YoY

Dividends

What is PBH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PBH.

Financial health

How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 66% higher than its total liabilities
The quick ratio has decreased by 27% YoY and by 15% from the previous quarter
PBH's total liabilities is down by 12% year-on-year and by 3.5% since the previous quarter
The company's debt is 12% higher than its equity
Prestige Consumer Healthcare's debt to equity has decreased by 26% YoY and by 7% from the previous quarter
The equity has grown by 16% YoY and by 2.7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.